These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33291301)

  • 1. Diagnostic Utility of Genome-Wide DNA Methylation Analysis in Mendelian Neurodevelopmental Disorders.
    Haghshenas S; Bhai P; Aref-Eshghi E; Sadikovic B
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional annotation of genomic variation: DNA methylation episignatures in neurodevelopmental Mendelian disorders.
    Sadikovic B; Levy MA; Aref-Eshghi E
    Hum Mol Genet; 2020 Sep; 29(R1):R27-R32. PubMed ID: 32644126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders.
    Aref-Eshghi E; Kerkhof J; Pedro VP; ; Barat-Houari M; Ruiz-Pallares N; Andrau JC; Lacombe D; Van-Gils J; Fergelot P; Dubourg C; Cormier-Daire V; Rondeau S; Lecoquierre F; Saugier-Veber P; Nicolas G; Lesca G; Chatron N; Sanlaville D; Vitobello A; Faivre L; Thauvin-Robinet C; Laumonnier F; Raynaud M; Alders M; Mannens M; Henneman P; Hennekam RC; Velasco G; Francastel C; Ulveling D; Ciolfi A; Pizzi S; Tartaglia M; Heide S; Héron D; Mignot C; Keren B; Whalen S; Afenjar A; Bienvenu T; Campeau PM; Rousseau J; Levy MA; Brick L; Kozenko M; Balci TB; Siu VM; Stuart A; Kadour M; Masters J; Takano K; Kleefstra T; de Leeuw N; Field M; Shaw M; Gecz J; Ainsworth PJ; Lin H; Rodenhiser DI; Friez MJ; Tedder M; Lee JA; DuPont BR; Stevenson RE; Skinner SA; Schwartz CE; Genevieve D; Sadikovic B
    Am J Hum Genet; 2020 Mar; 106(3):356-370. PubMed ID: 32109418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome.
    Bend EG; Aref-Eshghi E; Everman DB; Rogers RC; Cathey SS; Prijoles EJ; Lyons MJ; Davis H; Clarkson K; Gripp KW; Li D; Bhoj E; Zackai E; Mark P; Hakonarson H; Demmer LA; Levy MA; Kerkhof J; Stuart A; Rodenhiser D; Friez MJ; Stevenson RE; Schwartz CE; Sadikovic B
    Clin Epigenetics; 2019 Apr; 11(1):64. PubMed ID: 31029150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Methylation Possible Adjunct to Screening for Neurodevelopmental Syndromes: DNA methylation signatures were identified for several neurodevelopmental Mendelian disorders, and hold promise as a supplement to standard procedures for screening and detection of these diseases.
    Am J Med Genet A; 2018 Apr; 176(4):755-756. PubMed ID: 29575619
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of a DNA Methylation Signature for the Intellectual Developmental Disorder, X-Linked, Syndromic, Armfield Type.
    Haghshenas S; Levy MA; Kerkhof J; Aref-Eshghi E; McConkey H; Balci T; Siu VM; Skinner CD; Stevenson RE; Sadikovic B; Schwartz C
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional correlation of genome-wide DNA methylation profiles in genetic neurodevelopmental disorders.
    Levy MA; Relator R; McConkey H; Pranckeviciene E; Kerkhof J; Barat-Houari M; Bargiacchi S; Biamino E; Palomares Bralo M; Cappuccio G; Ciolfi A; Clarke A; DuPont BR; Elting MW; Faivre L; Fee T; Ferilli M; Fletcher RS; Cherick F; Foroutan A; Friez MJ; Gervasini C; Haghshenas S; Hilton BA; Jenkins Z; Kaur S; Lewis S; Louie RJ; Maitz S; Milani D; Morgan AT; Oegema R; Østergaard E; Pallares NR; Piccione M; Plomp AS; Poulton C; Reilly J; Rius R; Robertson S; Rooney K; Rousseau J; Santen GWE; Santos-Simarro F; Schijns J; Squeo GM; John MS; Thauvin-Robinet C; Traficante G; van der Sluijs PJ; Vergano SA; Vos N; Walden KK; Azmanov D; Balci TB; Banka S; Gecz J; Henneman P; Lee JA; Mannens MMAM; Roscioli T; Siu V; Amor DJ; Baynam G; Bend EG; Boycott K; Brunetti-Pierri N; Campeau PM; Campion D; Christodoulou J; Dyment D; Esber N; Fahrner JA; Fleming MD; Genevieve D; Heron D; Husson T; Kernohan KD; McNeill A; Menke LA; Merla G; Prontera P; Rockman-Greenberg C; Schwartz C; Skinner SA; Stevenson RE; Vincent M; Vitobello A; Tartaglia M; Alders M; Tedder ML; Sadikovic B
    Hum Mutat; 2022 Nov; 43(11):1609-1628. PubMed ID: 35904121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with
    Vos N; Reilly J; Elting MW; Campeau PM; Coman D; Stark Z; Tan TY; Amor DJ; Kaur S; StJohn M; Morgan AT; Kamien BA; Patel C; Tedder ML; Merla G; Prontera P; Castori M; Muru K; Collins F; Christodoulou J; Smith J; Zeev BB; Murgia A; Leonardi E; Esber N; Martinez-Monseny A; Casas-Alba D; Wallis M; Mannens M; Levy MA; Relator R; Alders M; Sadikovic B
    Epigenomics; 2023 Mar; 15(6):351-367. PubMed ID: 37249002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders.
    Levy MA; McConkey H; Kerkhof J; Barat-Houari M; Bargiacchi S; Biamino E; Bralo MP; Cappuccio G; Ciolfi A; Clarke A; DuPont BR; Elting MW; Faivre L; Fee T; Fletcher RS; Cherik F; Foroutan A; Friez MJ; Gervasini C; Haghshenas S; Hilton BA; Jenkins Z; Kaur S; Lewis S; Louie RJ; Maitz S; Milani D; Morgan AT; Oegema R; Østergaard E; Pallares NR; Piccione M; Pizzi S; Plomp AS; Poulton C; Reilly J; Relator R; Rius R; Robertson S; Rooney K; Rousseau J; Santen GWE; Santos-Simarro F; Schijns J; Squeo GM; St John M; Thauvin-Robinet C; Traficante G; van der Sluijs PJ; Vergano SA; Vos N; Walden KK; Azmanov D; Balci T; Banka S; Gecz J; Henneman P; Lee JA; Mannens MMAM; Roscioli T; Siu V; Amor DJ; Baynam G; Bend EG; Boycott K; Brunetti-Pierri N; Campeau PM; Christodoulou J; Dyment D; Esber N; Fahrner JA; Fleming MD; Genevieve D; Kerrnohan KD; McNeill A; Menke LA; Merla G; Prontera P; Rockman-Greenberg C; Schwartz C; Skinner SA; Stevenson RE; Vitobello A; Tartaglia M; Alders M; Tedder ML; Sadikovic B
    HGG Adv; 2022 Jan; 3(1):100075. PubMed ID: 35047860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes.
    Aref-Eshghi E; Rodenhiser DI; Schenkel LC; Lin H; Skinner C; Ainsworth P; Paré G; Hood RL; Bulman DE; Kernohan KD; ; Boycott KM; Campeau PM; Schwartz C; Sadikovic B
    Am J Hum Genet; 2018 Jan; 102(1):156-174. PubMed ID: 29304373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation episignature and comparative epigenomic profiling of HNRNPU-related neurodevelopmental disorder.
    Rooney K; van der Laan L; Trajkova S; Haghshenas S; Relator R; Lauffer P; Vos N; Levy MA; Brunetti-Pierri N; Terrone G; Mignot C; Keren B; de Villemeur TB; Volker-Touw CML; Verbeek N; van der Smagt JJ; Oegema R; Brusco A; Ferrero GB; Misra-Isrie M; Hochstenbach R; Alders M; Mannens MMAM; Sadikovic B; van Haelst MM; Henneman P
    Genet Med; 2023 Aug; 25(8):100871. PubMed ID: 37120726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive evaluation of the implementation of episignatures for diagnosis of neurodevelopmental disorders (NDDs).
    Giuili E; Grolaux R; Macedo CZNM; Desmyter L; Pichon B; Neuens S; Vilain C; Olsen C; Van Dooren S; Smits G; Defrance M
    Hum Genet; 2023 Dec; 142(12):1721-1735. PubMed ID: 37889307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of a strong episignature for Chung-Jansen syndrome, partially overlapping with Börjeson-Forssman-Lehmann and White-Kernohan syndromes.
    Vos N; Haghshenas S; van der Laan L; Russel PKM; Rooney K; Levy MA; Relator R; Kerkhof J; McConkey H; Maas SM; Vissers LELM; de Vries BBA; Pfundt R; Elting MW; van Hagen JM; Verbeek NE; Jongmans MCJ; Lakeman P; Rumping L; Bosch DGM; Vitobello A; Thauvin-Robinet C; Faivre L; Nambot S; Garde A; Willems M; Genevieve D; Nicolas G; Busa T; Toutain A; Gérard M; Bizaoui V; Isidor B; Merla G; Accadia M; Schwartz CE; Ounap K; Hoffer MJV; Nezarati MM; van den Boogaard MH; Tedder ML; Rogers C; Brusco A; Ferrero GB; Spodenkiewicz M; Sidlow R; Mussa A; Trajkova S; McCann E; Mroczkowski HJ; Jansen S; Donker-Kaat L; Duijkers FAM; Stuurman KE; Mannens MMAM; Alders M; Henneman P; White SM; Sadikovic B; van Haelst MM
    Hum Genet; 2024 Jun; 143(6):761-773. PubMed ID: 38787418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Utility of Genome-wide DNA Methylation Testing in Genetically Unsolved Individuals with Suspected Hereditary Conditions.
    Aref-Eshghi E; Bend EG; Colaiacovo S; Caudle M; Chakrabarti R; Napier M; Brick L; Brady L; Carere DA; Levy MA; Kerkhof J; Stuart A; Saleh M; Beaudet AL; Li C; Kozenko M; Karp N; Prasad C; Siu VM; Tarnopolsky MA; Ainsworth PJ; Lin H; Rodenhiser DI; Krantz ID; Deardorff MA; Schwartz CE; Sadikovic B
    Am J Hum Genet; 2019 Apr; 104(4):685-700. PubMed ID: 30929737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of DNA Methylation Signatures and Classification of Variants in Rare Neurodevelopmental Disorders Using EpigenCentral.
    Awamleh Z; Goodman S; Kallurkar P; Wu W; Lu K; Choufani S; Turinsky AL; Weksberg R
    Curr Protoc; 2022 Nov; 2(11):e597. PubMed ID: 36367395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Methylation Episignatures in Neurodevelopmental Disorders Associated with Large Structural Copy Number Variants: Clinical Implications.
    Rooney K; Sadikovic B
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DNA methylation episignature for the intellectual developmental disorder, autosomal dominant 21 syndrome, caused by variants in the CTCF gene.
    Karimi K; Mol MO; Haghshenas S; Relator R; Levy MA; Kerkhof J; McConkey H; Brooks A; Zonneveld-Huijssoon E; Gerkes EH; Tedder ML; Vissers L; Salzano E; Piccione M; Asaftei SD; Carli D; Mussa A; Shukarova-Angelovska E; Trajkova S; Brusco A; Merla G; Alders MM; Bouman A; Sadikovic B
    Genet Med; 2024 Mar; 26(3):101041. PubMed ID: 38054406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation episignature for Witteveen-Kolk syndrome due to SIN3A haploinsufficiency.
    Coenen-van der Spek J; Relator R; Kerkhof J; McConkey H; Levy MA; Tedder ML; Louie RJ; Fletcher RS; Moore HW; Childers A; Farrelly ER; Champaigne NL; Lyons MJ; Everman DB; Rogers RC; Skinner SA; Renck A; Matalon DR; Dills SK; Monteleone B; Demirdas S; Dingemans AJM; Donker Kaat L; Kolk SM; Pfundt R; Rump P; Sadikovic B; Kleefstra T; Butler KM
    Genet Med; 2023 Jan; 25(1):63-75. PubMed ID: 36399132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation episignature, extension of the clinical features, and comparative epigenomic profiling of Hao-Fountain syndrome caused by variants in USP7.
    van der Laan L; Karimi K; Rooney K; Lauffer P; McConkey H; Caro P; Relator R; Levy MA; Bhai P; Mignot C; Keren B; Briuglia S; Sobering AK; Li D; Vissers LELM; Dingemans AJM; Valenzuela I; Verberne EA; Misra-Isrie M; Zwijnenburg PJG; Waisfisz Q; Alders M; Sailer S; Schaaf CP; Mannens MMAM; Sadikovic B; van Haelst MM; Henneman P
    Genet Med; 2024 Mar; 26(3):101050. PubMed ID: 38126281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation signatures in mendelian developmental disorders as a diagnostic bridge between genotype and phenotype.
    Sadikovic B; Aref-Eshghi E; Levy MA; Rodenhiser D
    Epigenomics; 2019 Apr; 11(5):563-575. PubMed ID: 30875234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.